Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 08, 2021 08:30 ET | Source: 20/20 Global, Inc.

Mycotopia Therapies (20/20 Global) to Launch PsyBioMed, a Biosynthetic Compound, a Biotech Company for the Global Production of Psychedelics

MIAMI, Feb. 08, 2021 (GLOBE NEWSWIRE) -- Mycotopia Therapies (20/20 Global, Inc.), (OTC Pink: TWGL), a company focused on psychedelic therapies, is establishing a biosynthetic compound subsidiary...